Status:
COMPLETED
Cross Cultural Validation of the Italian Version of the Bt-DUX
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Quality of Life
Bone Neoplasm
Eligibility:
All Genders
15-25 years
Brief Summary
The purpose of the presented study is to translate the English Bt-DUX (Bt-DUX-Eng) questionnaire into the Italian language and then examine the validity of the Italian version of the Bt-DUX (Bt-DUX-It...
Detailed Description
Validation of the Italian Bt-DUX: Cross sectional study among patients of the Istituto Ortopedico Rizzoli, Bologna, Italy, will carry out. All patients who underwent a surgical intervention due to a ...
Eligibility Criteria
Inclusion
- Patients are eligible if they're aged between 15 and 25 years at the time of the selection, if the time since surgery is ranged between 12 and 60 months, if the malignant bone tumour (osteosarcoma or Ewing's sarcoma) was located around the hip or the knee and the surgical intervention consisted of limb sparing or ablative surgery.
Exclusion
- Patients will be excluded if other medical conditions limit their physical activities.
Key Trial Info
Start Date :
August 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04074291
Start Date
August 20 2019
End Date
January 30 2020
Last Update
May 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136